EBITDA Growth
13.01%
Quarterly · Period ending:
CNS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported13.01%period ending
Latest reported13.01%period ending
CNS Quarterly EBITDA YoY % (411.73% → 13.01%)
Year-over-year change
High-resolution chart · PNG
CNS ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 13.0101% | |
| 42.2127% | |
| 12.9757% | |
| -25.0372% | |
| -2.142% | |
| 13.2088% | |
| 13.9735% | |
| 20.3795% | |
| 7.5457% | |
| -6.0698% | |
| -12.1863% | |
| -12.61% | |
| -21.5598% | |
| -26.3218% | |
| -8.9629% | |
| -36.2309% | |
| -13.7923% | |
| 3.8036% | |
| 3.4709% | |
| 1,866.4939% | |
| 61.0214% | |
| 58.5223% | |
| 70.8709% | |
| -109.3694% | |
| -0.5621% | |
| -6.8332% | |
| -18.3301% | |
| 34.1604% | |
| 5.6532% | |
| 8.1876% | |
| 6.0291% | |
| -12.873% | |
| -0.9216% | |
| 3.0945% | |
| 0.4962% | |
| 14.3013% | |
| 9.9156% | |
| 7.6521% | |
| 23.8925% | |
| 9.3303% | |
| 18.8245% | |
| 11.0663% | |
| -15.5724% | |
| 3.2341% | |
| 7.7602% | |
| 1.2519% | |
| 25.1572% | |
| 7.9399% | |
| 5.2929% | |
| 5.5875% | |
| 28.7307% | |
| -13.6094% | |
| 108.2122% | |
| 8.7643% | |
| -17.5464% | |
| 51.9278% | |
| -40.4418% | |
| 16.4572% | |
| 36.3899% | |
| 69.7907% | |
| 56.8155% | |
| 67.4628% | |
| 47.9717% | |
| 15.4773% | |
| 119.2246% | |
| 895.5203% | |
| 1,073.9844% | |
| 44.4236% | |
| -54.16% | |
| -93.4436% | |
| -94.5535% | |
| -73.3294% | |
| -35.4306% | |
| -30.2961% | |
| -44.0488% | |
| 32.8061% | |
| 1.4121% | |
| 154.1043% | |
| 189.2063% | |
| 72.9393% | |
| 53.8627% | |
| -466.8605% | |
| -0.4701% | |
| -16.6807% | |
| 144.3374% | |
| 72.9858% | |
| 27.8101% | |
| 119.7733% | |
| -1,075.435% | |
| 411.7322% |